{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:24Z","timestamp":1793675124357,"version":"4.5.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.transci.2024.103991","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:36:21Z","timestamp":1724376981000},"page":"103991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Allogeneic serum-based eye drops may give better results than autologous drops in Sj\u00f6gren's syndrome dry eye"],"prefix":"10.1016","volume":"63","author":[{"given":"Joanna","family":"Janus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Chmielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Antoniewicz-Papis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transci.2024.103991_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.transci.2024.103991_bib2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.transci.2024.103991_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.transci.2024.103991_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ICO.0000000000000147","article-title":"Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sj\u00f6gren syndrome","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.transci.2024.103991_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2024.103991_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/vox.13413","article-title":"Eye drops of human origin-Current status and future needs: report on the workshop organized by the ISBT Working Party for Cellular Therapies","volume":"118","author":"Gabriel","year":"2023","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.transci.2024.103991_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103912","article-title":"Correlation between serum cytokine levels and the effect of allogeneic serum-based eye drops","volume":"63","author":"Chmielewska","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.transci.2024.103991_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aos.12801","article-title":"Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction","volume":"93","author":"Stenwall","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.transci.2024.103991_bib9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/ijms24021567","article-title":"Development of in vitro dry eye models to study proliferative and anti-inflammatory effects of allogeneic serum eye drops","volume":"24","author":"Vo\u00df","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.transci.2024.103991_bib10","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1038\/s41433-021-01560-8","article-title":"Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK","volume":"35","author":"Lomas","year":"2021","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.transci.2024.103991_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/aos.14788","article-title":"Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial","volume":"99","author":"van der Meer","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.transci.2024.103991_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/tme.12572","article-title":"A retrospective crossover study of autologous and allogeneic serum eye drops for the management of ocular surface disease","volume":"29","author":"Hung","year":"2019","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103991_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.02.009","article-title":"Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases","volume":"189","author":"Ali","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.transci.2024.103991_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1027199","volume":"225","author":"Harloff","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"issue":"2","key":"10.1016\/j.transci.2024.103991_bib15","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/aos.14953","article-title":"Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial","volume":"100","author":"Rodr\u00edguez Calvo-de-Mora","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"S1","key":"10.1016\/j.transci.2024.103991_bib16","first-page":"142","article-title":"Inactivation used in processing of allogenic \u2018artificial tears\u2019","volume":"117","author":"Chmielewska","year":"2022","journal-title":"Vox Sang"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T20:01:45Z","timestamp":1725998505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1473050224001629"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103991","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic serum-based eye drops may give better results than autologous drops in Sj\u00f6gren's syndrome dry eye","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103991"}}